The Advancement in Equine Research Award
Boehringer Ingelheim Vetmedica, Inc.
Attn: Dr. Steve Grubbs
3902 Gene Field Road
St. Joseph, Missouri 64506
Mark the envelope “The Advancement in Equine Research Award”
Value Through Innovation24 May 2013
Advancement in Equine Research Award
At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.
Scientists, researchers, practicing veterinarians, animal health companies, and horse owners have long been dedicated to improving the health of the horse. Yet the need for more knowledge in regards to disease prevention, lameness and general wellness still exists.
At Boehringer Ingelheim Vetmedica, Inc., we're furthering our commitment to research efforts to ensure that we continue to learn more about equine diseases.
We are pleased to announce the second annual Boehringer Ingelheim Advancement in Equine Research Award Program. The deadline for submissions is September 1, 2012.
The 2012 Advancement in Equine Research Awards recipients will be announced at the American Association of Equine Practitioners Conference in Anaheim, California.
The BIVI Equine Research Award will focus on one specific equine disease area each year. For 2012 the equine disease of focus is Pigeon Fever (Corynebacterium pseudotuberculosis).
Proposals must address one or more specific criteria to be considered:
- Pathophysiology of Corynebacterium pseudotuberculosis and development of an equine challenge model.
- Virulence factors and strain differences among isolates of Corynebacterium pseudotuberculosis isolated from internal and external infections and different geographic locations.
- Increased incidence and spread to different geographic locations and association with climate change.
- Comparison of host immunity between infections resulting in internal infection and recurrent infection in recovered horses.
- Seasonality of infection with Corynebacterium pseudotuberculosis and studies of insect vectors.
Boehringer Ingelheim will provide three $25,000 awards to the winning proposals for Pigeon Fever research in the US and Canada. Candidates include graduate students, academic researchers, company or private researchers, and practicing veterinarians. Winning proposals will be selected by an independent review board.
Once the three winning year-long research projects are completed and submitted for peer review, the Equine Research Review Board will conduct a second evaluation. Upon acceptance for publication of his or her findings, the first place award recipient will receive an additional U.S. $5,000; second place, $3,000; and third place, $1,000.
Our independent Equine Research Review Board members look forward to reviewing your proposal.
Submit Your Proposal To:
About Boehringer Ingelheim Vetmedica
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
As a central element of its culture, Boehringer Ingelheim pledges to act socially responsible. Involvement in social projects, caring for employees and their families, and providing equal opportunities for all employees form the foundation of the global operations. Mutual cooperation and respect, as well as environmental protection and sustainability are intrinsic factors in all of Boehringer Ingelheim’s endeavors.
In 2011, Boehringer Ingelheim achieved net sales of about $17.1 billion (13.2 billion euro). R&D expenditure in the business area Prescription Medicines corresponds to 23.5% of its net sales.
For more information, please visit http://us.boehringer-ingelheim.com and follow us on Twitter at http://twitter.com/boehringerus.
Contact Us
-
The Advancement in Equine Research Award
Boehringer Ingelheim Vetmedica, Inc.
Attn: Dr. Steve Grubbs
3902 Gene Field Road
St. Joseph, Missouri 64506
